Search results for "type 2"

showing 10 items of 1034 documents

[Arterial hypertension and prediabetes].

2016

Abstract Background and objectives The aim of this study was to assess the factors related to new diabetes in hypertensive. Patients and methods This prospective follow-up study involved 2588 non-diabetic, hypertensive patients. The total follow-up was 15,053 patient-years with a median of 3.4 years (interquartile interval 1.4–6.8). Results During the follow-up, 333 (13%) patients had new diabetes, with a conversion rate of 2.21 (95% confidence interval [CI], 1.98–2.46) 100/patients/year. In a Cox proportional hazard model including baseline characteristics and modifications during the follow-up the three components of metabolic syndrome (excluding blood pressure and glucose values) HR 1.69…

AdultMalemedicine.medical_specialty030204 cardiovascular system & hematologyPrediabetic State03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsDiabetes mellitusInternal medicinemedicineHumans030212 general & internal medicinePrediabetesProspective StudiesFamily historyAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelMiddle Agedmedicine.diseaseCombined Modality TherapyConfidence intervalPrimary PreventionEndocrinologyBlood pressureDiabetes Mellitus Type 2HypertensionFemaleMetabolic syndromebusinessFollow-Up StudiesMedicina clinica
researchProduct

Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: evaluation of …

1999

Aims/hypothesis. The aim of this study was to screen part of the putative promoter sequence in addition to 14 potential phosphotyrosine residues of human IRS-2 for genetic variability which might cause changes in protein expression or function. Furthermore, the potential impact on insulin secretion and sensitivity of a previously identified IRS-2 variant (Gly1057Asp) was analysed Methods. The screenings were carried out by the SSCP-heteroduplex technique on DNA from Type II (non-insulin-dependent) diabetic patients. The impact of the Gly1057Asp variant was analysed in four glucose-tolerant Scandinavian study groups. Results. The results showed no nucleotide substitutions in the promoter seq…

AdultMalemedicine.medical_specialtyAdolescentInsulin Receptor Substrate ProteinsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMolecular Sequence Datamedicine.disease_causeGene FrequencyTwo-Hybrid System TechniquesInternal medicineDiabetes mellitusInsulin SecretionInternal MedicinemedicineHumansInsulinGenetic TestingProspective StudiesPhosphotyrosinePromoter Regions GeneticPolymorphism Single-Stranded ConformationalPancreatic hormoneAgedMutationGlucose tolerance testBase Sequencebiologymedicine.diagnostic_testGenetic Carrier ScreeningInsulinIntracellular Signaling Peptides and ProteinsGlucose Tolerance TestMiddle AgedPhosphoproteinsmedicine.diseaseIRS2PedigreeInsulin receptorEndocrinologyAmino Acid SubstitutionDiabetes Mellitus Type 2Insulin Receptor Substrate Proteinsbiology.proteinDiabetologia
researchProduct

Polymorphonuclear leukocyte membrane fluidity before and after activation in subjects with insulin resistance.

2000

The aim of this research was the evaluation of polymorphonuclear leukocyte (PMN) membrane fluidity in subjects with insulin resistance. Insulin sensitivity, in fact, may be influenced by plasma membrane fluidity. We enrolled 19 subjects with insulin resistance previously demonstrated during an euglycemic hyperinsulinemic clamp. PMN membrane fluidity was studied by labeling intact cells with the fluorescent probe 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene and calculating the fluorescence polarization degree. The measurement was made before and after incubation of PMNs with two activating agents: 4-phorbol 12-myristate 13-acetate (PMA) and N-formyl-methionyl-leucyl-phenylalanine (…

AdultMalemedicine.medical_specialtyAdolescentMembrane FluidityNeutrophilsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentIn Vitro TechniquesNeutrophil Activationchemistry.chemical_compoundEndocrinologyInsulin resistanceReference ValuesDiabetes mellitusInternal medicineHyperinsulinismGlucose IntoleranceInternal MedicinemedicineMembrane fluidityHumansObesityChildPancreatic hormoneChemistryInsulinhemic and immune systemsGeneral MedicineN-Formylmethionine leucyl-phenylalanineGlucose clamp techniqueMiddle Agedmedicine.diseaseN-Formylmethionine Leucyl-PhenylalanineEndocrinologyDiabetes Mellitus Type 2Glucose Clamp TechniqueTetradecanoylphorbol AcetateFemaleInsulin ResistanceHyperinsulinismActa diabetologica
researchProduct

Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

2013

Abstract Introduction Dyslipidemia is a significant contributor to the elevated CVD risk observed in type 2 diabetes mellitus. We assessed the prevalence of dyslipidemia and its association with glucose metabolism status in a representative sample of the adult population in Spain and the percentage of subjects at guideline-recommended LDL-C goals. Material and methods The di@bet.es study is a national, cross-sectional population-based survey of 5728 adults. Results A total of 4776 subjects were studied. Dyslipidemia was diagnosed in 56.8% of subjects; only 13.2% of subjects were treated with lipid lowering drugs. Lipid abnormalities were found in 56.8% of Spanish adults: 23.3% with high LDL…

AdultMalemedicine.medical_specialtyAdolescentPopulationAdult populationCarbohydrate metabolismPrediabetic StateYoung AdultRisk FactorsInternal medicinePlasma lipidsPrevalencemedicineHumansPharmacology (medical)educationAgedDyslipidemiasHypolipidemic Agentseducation.field_of_studybusiness.industryCholesterol HDLType 2 Diabetes MellitusCholesterol LDLMiddle Agedmedicine.diseaseSpanish populationCross-Sectional StudiesGlucoseEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesSpainFemalelipids (amino acids peptides and proteins)Lipid loweringCardiology and Cardiovascular MedicinebusinessDyslipidemiaClínica e Investigación en Arteriosclerosis
researchProduct

The Influence of Insulin on Local Amyloidosis of the Islets of Langerhans and Insulinoma

1980

Summary Amyloid-containing islets of Langerhans from the pancreas of 75 diabetics and one case of an amyloid-containing insulinoma were investigated. By light and electron microscopy, amyloid deposits were observed between the B cells and adjacent capillaries. The cytoplasm of B cells and extracellular amyloid display immunohistological binding of anti-insulin antibody. Correspondingly, ferritin-labeled anti-insulin antibody was found by electron microscopy on and between the amyloid fibrils. Insulin or proinsulin (or a protein closely related to insulin) thus appears to be a.component of the protein which constitutes the amyloid. The molecular weight and mode of deposition of this form of …

AdultMalemedicine.medical_specialtyAmyloidmedicine.medical_treatmentPathology and Forensic MedicineIslets of LangerhansInsulin-Secreting CellsInternal medicinemental disordersExtracellularmedicineHumansHypoglycemic AgentsInsulinInsulinomaAgedProinsulinAged 80 and overbiologyChemistryInsulinAmyloidosisAmyloidosisCell BiologyMiddle Agedmedicine.diseaseImmunohistochemistryPancreatic NeoplasmsMicroscopy Electronmedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2biology.proteinFemaleInsulinomaAntibodyPancreasPathology - Research and Practice
researchProduct

Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina

1991

PAI-1 antigen, tPA antigen and thrombin - antithrombin III complexes (TAT) levels were measured in 10 males with stable angina and type-II diabetes mellitus and in 16 males with stable angina without diabetes or other risk factors (hyperfibrinogenaemia, hyperlipidaemia, diabetes, hypertension, smoking and obesity) known to increase PAI levels. Ten healthy men of equivalent age served as controls. Because only diabetics with coronary artery disease (CAD) showed a decreased fibrinolytic capacity, a second study was performed on the 16 non-diabetic CAD patients to determine whether submaximal workload induces significant changes of tPA and PAI levels. TAT levels were increased in CAD, and sign…

AdultMalemedicine.medical_specialtyAntithrombin IIICoronary DiseaseStable anginaAngina PectorisFibrin Fibrinogen Degradation ProductsCoronary artery diseaseThrombinAntigenDiabetes mellitusInternal medicinemedicineHumanscardiovascular diseasesAgedbusiness.industryFibrinolysisPlasminogen activator inhibitor antigenAntithrombinFibrinogenHematologyGeneral MedicineMiddle Agedmedicine.diseaseObesityPlasminogen InactivatorsEndocrinologyDiabetes Mellitus Type 2Tissue Plasminogen ActivatorExercise TestbusinessPeptide Hydrolasesmedicine.drugBlood Coagulation & Fibrinolysis
researchProduct

Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients

2009

Although many studies have shown that the metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) both are associated with chronic inflammatory state and are risk factors for coronary artery disease (CAD), it is still unclear which condition is a more important contributor to the increased production of inflammatory chemokines. The purpose of this study was to assess monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels and their association with insulin resistance and adiponectin concentrations in CAD patients, who were categorized as having T2DM, MS, or neither.CAD male patients were categorized into three groups: 24 non-obese patients with T2DM (D), 24 obese pati…

AdultMalemedicine.medical_specialtyChemokineDecreased adiponectinCoronary Artery DiseaseCoronary artery diseaseInsulin resistanceRisk FactorsInternal medicineInternal MedicinemedicineHumansObesityChemokine CCL2AgedMetabolic SyndromeAdiponectinbiologybusiness.industryMonocyteInterleukin-8nutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseasemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2biology.proteinAdiponectinInsulin ResistanceMetabolic syndromebusinessBiomarkersEuropean Journal of Internal Medicine
researchProduct

Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

2021

Abstract Background and aims Obesity is a key contributing factor to incidental type 2 diabetes and cardiovascular disease. CXCR3 receptor and its ligands CXCL 10 and 11 are associated with atherosclerosis and cardiovascular disease. The aim of our study was to analyse the role of the CXCR3 ligands on insulin resistance (IR) and endothelial dysfunction in human obesity. Methods and results We have studied 45 obese patients (mean age 44 ± 6 years, body mass index 45 ± 9 kg/m2) who were selected for Roux-Y-gastric bypass surgery and 21 non obese control subjects with similar age and gender distribution. We measured by ELISA the circulating levels of the CXCR3 ligands interferon-γ inducible pr…

AdultMalemedicine.medical_specialtyChemokineReceptors CXCR3Type 2 diabetesCXCR3BiochemistryInsulin resistanceInternal medicineCell AdhesionLeukocytesmedicineHumansCXCL10CXCL11ObesityEndothelial dysfunctionCells CulturedbiologyTumor Necrosis Factor-alphabusiness.industryEndothelial CellsCell BiologyMiddle Agedmedicine.diseaseChemokine CXCL11Up-RegulationChemokine CXCL10EndocrinologyCase-Control Studiesbiology.proteinFemaleInsulin ResistanceCardiology and Cardiovascular MedicinebusinessBody mass indexSignal TransductionMicrovascular Research
researchProduct

A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in S…

2014

In Spain, data suggest that 13.8% of adults have diabetes. Two important aspects in diabetes management are mild hypoglycemic episodes and poor treatment adherence. This study assesses the impact of missed insulin doses and prevalence of mistimed and reduced insulin doses and mild hypoglycemia in patients with type 2 diabetes treated with basal insulin analogues in Spain, and compares the data collected to pooled data from 8 other European countries (OECs).GAPP2 was an international, online, cross-sectional study of diabetic patients aged ≥40 years treated with long-acting insulin analogues and their healthcare professionals. Patients and healthcare professionals were recruited from online …

AdultMalemedicine.medical_specialtyCross-sectional studyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentHealth PersonnelType 2 diabetesHypoglycemiaSeverity of Illness IndexMedication AdherenceEndocrinologyQuality of lifeDiabetes managementInternal medicineDiabetes mellitusSurveys and QuestionnairesmedicineHumansHypoglycemic AgentsInsulinDosingAgedAged 80 and overbusiness.industryInsulinMiddle Agedmedicine.diseaseHypoglycemiaSurgeryEuropeSelf CareCross-Sectional StudiesDiabetes Mellitus Type 2SpainFemalebusinessEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
researchProduct

Predictive model to identify the risk of losing protective sensibility of the foot in patients with diabetes mellitus

2019

Diabetic neuropathy is defined as the presence of symptoms and signs of peripheral nerve dysfunction in diabetics. The aim of this study is to develop a predictive logistic model to identify the risk of losing protective sensitivity in the foot. This descriptive cross‐sectional study included 111 patients diagnosed with diabetes mellitus. Participants completed a questionnaire designed to evaluate neuropathic symptoms, and multivariate analysis was subsequently performed to identify an optimal predictive model. The explanatory capacity was evaluated by calculating the R (2) coefficient of Nagelkerke. Predictive capacity was evaluated by calculating sensitivity, specificity, and estimation o…

AdultMalemedicine.medical_specialtyDiabetic neuropathyMultivariate analysismellitus diabetesDermatologyLogistic regressionRisk AssessmentSeverity of Illness Index030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDiabetic NeuropathiesPeripheral nerveRisk FactorsInternal medicineDiabetes mellitusClinical Decision RulesmedicineHumansIn patient030212 general & internal medicineAgedAged 80 and overbusiness.industryOriginal ArticlesMiddle Agedmedicine.diseasepredictive modelsDiabetic footdiabetic neuropathyDiabetic FootCross-Sectional StudiesDiabetes Mellitus Type 1Logistic ModelsDiabetes Mellitus Type 2Sensory ThresholdsSurgeryFemalebusinessFoot (unit)diabetic foot
researchProduct